Neuronetics (STIM) Capital Expenditures (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.45% |
| Dec 31, 2025 | 274.83% |
| Sep 30, 2025 | -275.00% |
| Jun 30, 2025 | 15.07% |
| Mar 31, 2025 | 116.06% |
| Dec 31, 2024 | -453.37% |
| Sep 30, 2024 | -50.58% |
| Jun 30, 2024 | 271.90% |
| Mar 31, 2024 | 318.75% |
| Dec 31, 2023 | 84.08% |
| Sep 30, 2023 | -185.65% |
| Jun 30, 2023 | 200.85% |
| Mar 31, 2023 | -53.48% |
| Dec 31, 2022 | -30.72% |
| Sep 30, 2022 | -24.84% |
| Jun 30, 2022 | -10.06% |
| Mar 31, 2022 | 959.20% |
| Dec 31, 2021 | -135.01% |
| Sep 30, 2021 | 346.21% |
| Jun 30, 2021 | -177.96% |
| Mar 31, 2021 | -71.25% |
| Dec 31, 2020 | 21,466.67% |
| Sep 30, 2020 | 121.43% |
| Jun 30, 2020 | -114.89% |
| Mar 31, 2020 | -72.83% |
| Dec 31, 2019 | 1,822.22% |
| Sep 30, 2019 | 158.06% |
| Jun 30, 2019 | -170.45% |
| Mar 31, 2019 | 111.37% |
| Dec 31, 2018 | -382.48% |
| Sep 30, 2018 | -36.57% |
| Jun 30, 2018 | -27.27% |
| Mar 31, 2018 | 208.39% |
| Dec 31, 2017 | -264.07% |